{"id":"https://openalex.org/W4361877624","doi":"https://doi.org/10.1158/0008-5472.22425546","title":"Supplementary Table 1 from Structural Optimization and Enhanced Prodrug-Mediated Delivery Overcomes Camptothecin Resistance in High-Risk Solid Tumors","display_name":"Supplementary Table 1 from Structural Optimization and Enhanced Prodrug-Mediated Delivery Overcomes Camptothecin Resistance in High-Risk Solid Tumors","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361877624","doi":"https://doi.org/10.1158/0008-5472.22425546"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.22425546","doi":"https://doi.org/10.1158/0008-5472.22425546","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.22425546","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/0008-5472.22425546","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052318072","display_name":"Ferro Nguyen","orcid":"https://orcid.org/0000-0001-6640-8445","observed_orcids":["https://orcid.org/0000-0001-6640-8445"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ferro Nguyen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102441904","display_name":"Peng Guan","orcid":"https://orcid.org/0009-0009-8655-3346","observed_orcids":["https://orcid.org/0009-0009-8655-3346"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peng Guan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050305140","display_name":"David T. Guerrero","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David T. Guerrero","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002567610","display_name":"Venkatadri Kolla","orcid":"https://orcid.org/0000-0002-2385-3407","observed_orcids":["https://orcid.org/0000-0002-2385-3407"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Venkatadri Kolla","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014545584","display_name":"Koumudi Naraparaju","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Koumudi Naraparaju","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066536305","display_name":"Lauren M. Perry","orcid":"https://orcid.org/0000-0003-0343-3453","observed_orcids":["https://orcid.org/0000-0003-0343-3453"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lauren M. Perry","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0343-3453","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084751957","display_name":"Danielle Soberman","orcid":"https://orcid.org/0000-0003-3763-9476","observed_orcids":["https://orcid.org/0000-0003-3763-9476"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Danielle Soberman","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3763-9476","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081453997","display_name":"Benjamin B. Pressly","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Benjamin B. Pressly","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009569107","display_name":"Ivan S. Alferiev","orcid":"https://orcid.org/0000-0002-7849-750X","observed_orcids":["https://orcid.org/0000-0002-7849-750X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ivan S. Alferiev","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055602430","display_name":"Michael Chorny","orcid":"https://orcid.org/0000-0002-8243-9089","observed_orcids":["https://orcid.org/0000-0002-8243-9089"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Chorny","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5004950779","display_name":"Garrett M. Brodeur","orcid":"https://orcid.org/0000-0002-6721-122X","observed_orcids":["https://orcid.org/0000-0002-6721-122X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Garrett M. Brodeur","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6721-122X","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.9291999936103821,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.9291999936103821,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.03680000081658363,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.017100000753998756,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/camptothecin-resistance","display_name":"camptothecin resistance","score":0.9380000233650208},{"id":"https://openalex.org/keywords/prodrugs","display_name":"prodrugs","score":0.6209999918937683},{"id":"https://openalex.org/keywords/sn-38","display_name":"SN-38","score":0.9980000257492065},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9330000281333923},{"id":"https://openalex.org/keywords/structural-optimization","display_name":"structural optimization","score":0.8479999899864197},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.7490000128746033},{"id":"https://openalex.org/keywords/topoisomerase-i-inhibitor","display_name":"topoisomerase I inhibitor","score":0.8100000023841858}],"concepts":[{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.9184842109680176},{"id":"https://openalex.org/C2779682216","wikidata":"https://www.wikidata.org/wiki/Q419964","display_name":"Camptothecin","level":2,"score":0.8508120179176331},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6780534386634827},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.47246336936950684},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3847048878669739},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.3679247498512268},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3157654404640198},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.19656473398208618}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/0008-5472.22425546","doi":"https://doi.org/10.1158/0008-5472.22425546","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.22425546","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/0008-5472.22425546.v1","doi":"https://doi.org/10.1158/0008-5472.22425546.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.22425546.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_1_from_Structural_Optimization_and_Enhanced_Prodrug-Mediated_Delivery_Overcomes_Camptothecin_Resistance_in_High-Risk_Solid_Tumors/22425546/1/files/39871842.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22425546","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Table_1_from_Structural_Optimization_and_Enhanced_Prodrug-Mediated_Delivery_Overcomes_Camptothecin_Resistance_in_High-Risk_Solid_Tumors/22425546","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.22425546","doi":"https://doi.org/10.1158/0008-5472.22425546","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.22425546","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361877624.pdf","grobid_xml":"https://content.openalex.org/works/W4361877624.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3080095163","https://openalex.org/W4361823076","https://openalex.org/W4213416356","https://openalex.org/W2069354254","https://openalex.org/W2091899834","https://openalex.org/W7099195564","https://openalex.org/W2287141055","https://openalex.org/W2004548757","https://openalex.org/W2010936618","https://openalex.org/W1995767891"],"abstract_inverted_index":{"SN22":[0],"and":[1],"SN38":[2],"pharmacokinetics":[3]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}
